Overview
Polysaccharide that primes innate immune cells (yeast) or lowers cholesterol (oat).
- Baker's yeast
- Oats
- Mushrooms
- Yeast beta-1,3/1,6-glucan
- Oat beta-glucan
Mechanism of action
Activates Dectin-1 on innate immune cells (yeast); binds bile acids (oat).
- · Dectin-1 / TLR2 activation
- · Bile acid binding
Effects on the body
Organ system effects
Oat beta-glucan lowers LDL.
Evidence-based benefits
Reduces URI in stressed athletes (yeast)
Moderate evidenceReduces LDL (oat, 3 g/d)
Strong evidencePotential side effects
Drug interactions
No notable interactions reported.
Safety & non-supplemental interactions
Educational summary — always confirm with your clinician or pharmacist before starting, stopping, or combining with prescription therapy.
- ·Autoimmune disease (theoretical immune activation)
- ·Immunosuppressants
Supplement interactions
None listed.
No specific avoidances listed.
Dosing & bioavailability
Where to buy
Affiliate-style search links to reputable retailers. We don't endorse specific brands — verify third-party testing (USP, NSF, Informed Sport) before purchase.
Scientific evidence (9)
Beta-1,3/1,6-glucan and immune function
Auinger A, et al.
16-week RCT of yeast beta-glucan.
Reduced URTI incidence and severity.
PubMed: Beta-Glucan — Reduces URI in stressed athletes
Live PubMed search
Live results for "Beta-Glucan Reduces URI in stressed athletes" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "Reduces URI in stressed athletes". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Beta-Glucan — Reduces LDL
Live PubMed search
Live results for "Beta-Glucan Reduces LDL" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "Reduces LDL". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Beta-Glucan — randomized controlled trial
Live PubMed search
Live results for "Beta-Glucan randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Beta-Glucan — meta-analysis
Live PubMed search
Live results for "Beta-Glucan meta-analysis" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Beta-Glucan — pharmacokinetics
Live PubMed search
Live results for "Beta-Glucan pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Beta-Glucan — safety adverse events
Live PubMed search
Live results for "Beta-Glucan safety adverse events" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Beta-Glucan — dose response
Live PubMed search
Live results for "Beta-Glucan dose response" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Beta-Glucan and "dose response". Filter by RCT, meta-analysis, or year on the results page.
Google Scholar: Beta-Glucan — clinical evidence
Live Scholar search
Cross-database citation index for Beta-Glucan as it relates to "clinical evidence".
Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.